1 Combined hormonal contraceptive Market Overview 1.1 Product Overview and Scope of Combined hormonal contraceptive 1.2 Combined hormonal contraceptive Segment by Type 1.2.1 Global Combined hormonal contraceptive Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Pills 1.2.3 Patch 1.2.4 Ring 1.3 Combined hormonal contraceptive Segment by Application 1.3.1 Combined hormonal contraceptive Sales Comparison by Application: (2021-2027) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 E-commerce 1.3.5 Others 1.4 Global Combined hormonal contraceptive Market Size Estimates and Forecasts 1.4.1 Global Combined hormonal contraceptive Revenue 2016-2027 1.4.2 Global Combined hormonal contraceptive Sales 2016-2027 1.4.3 Combined hormonal contraceptive Market Size by Region: 2016 Versus 2021 Versus 2027 2 Combined hormonal contraceptive Market Competition by Manufacturers 2.1 Global Combined hormonal contraceptive Sales Market Share by Manufacturers (2016-2021) 2.2 Global Combined hormonal contraceptive Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Combined hormonal contraceptive Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Combined hormonal contraceptive Manufacturing Sites, Area Served, Product Type 2.5 Combined hormonal contraceptive Market Competitive Situation and Trends 2.5.1 Combined hormonal contraceptive Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Combined hormonal contraceptive Players Market Share by Revenue 2.5.3 Global Combined hormonal contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Combined hormonal contraceptive Retrospective Market Scenario by Region 3.1 Global Combined hormonal contraceptive Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Combined hormonal contraceptive Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Combined hormonal contraceptive Market Facts & Figures by Country 3.3.1 North America Combined hormonal contraceptive Sales by Country 3.3.2 North America Combined hormonal contraceptive Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Combined hormonal contraceptive Market Facts & Figures by Country 3.4.1 Europe Combined hormonal contraceptive Sales by Country 3.4.2 Europe Combined hormonal contraceptive Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Combined hormonal contraceptive Market Facts & Figures by Region 3.5.1 Asia Pacific Combined hormonal contraceptive Sales by Region 3.5.2 Asia Pacific Combined hormonal contraceptive Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Combined hormonal contraceptive Market Facts & Figures by Country 3.6.1 Latin America Combined hormonal contraceptive Sales by Country 3.6.2 Latin America Combined hormonal contraceptive Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Combined hormonal contraceptive Market Facts & Figures by Country 3.7.1 Middle East and Africa Combined hormonal contraceptive Sales by Country 3.7.2 Middle East and Africa Combined hormonal contraceptive Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Combined hormonal contraceptive Historic Market Analysis by Type 4.1 Global Combined hormonal contraceptive Sales Market Share by Type (2016-2021) 4.2 Global Combined hormonal contraceptive Revenue Market Share by Type (2016-2021) 4.3 Global Combined hormonal contraceptive Price by Type (2016-2021) 5 Global Combined hormonal contraceptive Historic Market Analysis by Application 5.1 Global Combined hormonal contraceptive Sales Market Share by Application (2016-2021) 5.2 Global Combined hormonal contraceptive Revenue Market Share by Application (2016-2021) 5.3 Global Combined hormonal contraceptive Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Teva Pharmaceutical Industries 6.1.1 Teva Pharmaceutical Industries Corporation Information 6.1.2 Teva Pharmaceutical Industries Description and Business Overview 6.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Teva Pharmaceutical Industries Product Portfolio 6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates 6.2 Bayer HealthCare Pharmaceuticals 6.2.1 Bayer HealthCare Pharmaceuticals Corporation Information 6.2.2 Bayer HealthCare Pharmaceuticals Description and Business Overview 6.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Bayer HealthCare Pharmaceuticals Product Portfolio 6.2.5 Bayer HealthCare Pharmaceuticals Recent Developments/Updates 6.3 Actavis 6.3.1 Actavis Corporation Information 6.3.2 Actavis Description and Business Overview 6.3.3 Actavis Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Actavis Product Portfolio 6.3.5 Actavis Recent Developments/Updates 6.4 Pfizer 6.4.1 Pfizer Corporation Information 6.4.2 Pfizer Description and Business Overview 6.4.3 Pfizer Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Pfizer Product Portfolio 6.4.5 Pfizer Recent Developments/Updates 6.5 Johnson & Johnson 6.5.1 Johnson & Johnson Corporation Information 6.5.2 Johnson & Johnson Description and Business Overview 6.5.3 Johnson & Johnson Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Johnson & Johnson Product Portfolio 6.5.5 Johnson & Johnson Recent Developments/Updates 6.6 GlaxoSmithKline 6.6.1 GlaxoSmithKline Corporation Information 6.6.2 GlaxoSmithKline Description and Business Overview 6.6.3 GlaxoSmithKline Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.6.4 GlaxoSmithKline Product Portfolio 6.6.5 GlaxoSmithKline Recent Developments/Updates 6.7 Watson Pharma 6.6.1 Watson Pharma Corporation Information 6.6.2 Watson Pharma Description and Business Overview 6.6.3 Watson Pharma Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Watson Pharma Product Portfolio 6.7.5 Watson Pharma Recent Developments/Updates 6.8 Cipla 6.8.1 Cipla Corporation Information 6.8.2 Cipla Description and Business Overview 6.8.3 Cipla Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Cipla Product Portfolio 6.8.5 Cipla Recent Developments/Updates 6.9 Novartis International 6.9.1 Novartis International Corporation Information 6.9.2 Novartis International Description and Business Overview 6.9.3 Novartis International Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Novartis International Product Portfolio 6.9.5 Novartis International Recent Developments/Updates 7 Combined hormonal contraceptive Manufacturing Cost Analysis 7.1 Combined hormonal contraceptive Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Combined hormonal contraceptive 7.4 Combined hormonal contraceptive Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Combined hormonal contraceptive Distributors List 8.3 Combined hormonal contraceptive Customers 9 Combined hormonal contraceptive Market Dynamics 9.1 Combined hormonal contraceptive Industry Trends 9.2 Combined hormonal contraceptive Growth Drivers 9.3 Combined hormonal contraceptive Market Challenges 9.4 Combined hormonal contraceptive Market Restraints 10 Global Market Forecast 10.1 Combined hormonal contraceptive Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Combined hormonal contraceptive by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Combined hormonal contraceptive by Type (2022-2027) 10.2 Combined hormonal contraceptive Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Combined hormonal contraceptive by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Combined hormonal contraceptive by Application (2022-2027) 10.3 Combined hormonal contraceptive Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Combined hormonal contraceptive by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Combined hormonal contraceptive by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Combined hormonal contraceptive Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Combined hormonal contraceptive Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Combined hormonal contraceptive Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Combined hormonal contraceptive Covered in This Study Table 5. Global Combined hormonal contraceptive Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Combined hormonal contraceptive Sales Share by Manufacturers (2016-2021) Table 7. Global Combined hormonal contraceptive Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Combined hormonal contraceptive Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Combined hormonal contraceptive Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Combined hormonal contraceptive Manufacturing Sites and Area Served Table 11. Manufacturers Combined hormonal contraceptive Product Type Table 12. Global Combined hormonal contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Combined hormonal contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Combined hormonal contraceptive as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Combined hormonal contraceptive Sales by Region (2016-2021) & (K MT) Table 16. Global Combined hormonal contraceptive Sales Market Share by Region (2016-2021) Table 17. Global Combined hormonal contraceptive Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Combined hormonal contraceptive Sales by Country (2016-2021) & (K MT) Table 19. North America Combined hormonal contraceptive Sales Market Share by Country (2016-2021) Table 20. North America Combined hormonal contraceptive Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Combined hormonal contraceptive Revenue Market Share by Country (2016-2021) Table 22. Europe Combined hormonal contraceptive Sales by Country (2016-2021) & (K MT) Table 23. Europe Combined hormonal contraceptive Sales Market Share by Country (2016-2021) Table 24. Europe Combined hormonal contraceptive Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Combined hormonal contraceptive Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Combined hormonal contraceptive Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Combined hormonal contraceptive Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Combined hormonal contraceptive Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Combined hormonal contraceptive Revenue Market Share by Region (2016-2021) Table 30. Latin America Combined hormonal contraceptive Sales by Country (2016-2021) & (K MT) Table 31. Latin America Combined hormonal contraceptive Sales Market Share by Country (2016-2021) Table 32. Latin America Combined hormonal contraceptive Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Combined hormonal contraceptive Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Combined hormonal contraceptive Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Combined hormonal contraceptive Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Combined hormonal contraceptive Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Combined hormonal contraceptive Revenue Market Share by Country (2016-2021) Table 38. Global Combined hormonal contraceptive Sales (K MT) by Type (2016-2021) Table 39. Global Combined hormonal contraceptive Sales Market Share by Type (2016-2021) Table 40. Global Combined hormonal contraceptive Revenue (Million US$) by Type (2016-2021) Table 41. Global Combined hormonal contraceptive Revenue Share by Type (2016-2021) Table 42. Global Combined hormonal contraceptive Price (USD/MT) by Type (2016-2021) Table 43. Global Combined hormonal contraceptive Sales (K MT) by Application (2016-2021) Table 44. Global Combined hormonal contraceptive Sales Market Share by Application (2016-2021) Table 45. Global Combined hormonal contraceptive Revenue (Million US$) by Application (2016-2021) Table 46. Global Combined hormonal contraceptive Revenue Share by Application (2016-2021) Table 47. Global Combined hormonal contraceptive Price (USD/MT) by Application (2016-2021) Table 48. Teva Pharmaceutical Industries Corporation Information Table 49. Teva Pharmaceutical Industries Description and Business Overview Table 50. Teva Pharmaceutical Industries Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Teva Pharmaceutical Industries Combined hormonal contraceptive Product Table 52. Teva Pharmaceutical Industries Recent Developments/Updates Table 53. Bayer HealthCare Pharmaceuticals Corporation Information Table 54. Bayer HealthCare Pharmaceuticals Description and Business Overview Table 55. Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Product Table 57. Bayer HealthCare Pharmaceuticals Recent Developments/Updates Table 58. Actavis Corporation Information Table 59. Actavis Description and Business Overview Table 60. Actavis Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Actavis Combined hormonal contraceptive Product Table 62. Actavis Recent Developments/Updates Table 63. Pfizer Corporation Information Table 64. Pfizer Description and Business Overview Table 65. Pfizer Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Pfizer Combined hormonal contraceptive Product Table 67. Pfizer Recent Developments/Updates Table 68. Johnson & Johnson Corporation Information Table 69. Johnson & Johnson Description and Business Overview Table 70. Johnson & Johnson Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Johnson & Johnson Combined hormonal contraceptive Product Table 72. Johnson & Johnson Recent Developments/Updates Table 73. GlaxoSmithKline Corporation Information Table 74. GlaxoSmithKline Description and Business Overview Table 75. GlaxoSmithKline Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. GlaxoSmithKline Combined hormonal contraceptive Product Table 77. GlaxoSmithKline Recent Developments/Updates Table 78. Watson Pharma Corporation Information Table 79. Watson Pharma Description and Business Overview Table 80. Watson Pharma Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Watson Pharma Combined hormonal contraceptive Product Table 82. Watson Pharma Recent Developments/Updates Table 83. Cipla Corporation Information Table 84. Cipla Description and Business Overview Table 85. Cipla Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. Cipla Combined hormonal contraceptive Product Table 87. Cipla Recent Developments/Updates Table 88. Novartis International Corporation Information Table 89. Novartis International Description and Business Overview Table 90. Novartis International Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Novartis International Combined hormonal contraceptive Product Table 92. Novartis International Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Combined hormonal contraceptive Distributors List Table 96. Combined hormonal contraceptive Customers List Table 97. Combined hormonal contraceptive Market Trends Table 98. Combined hormonal contraceptive Growth Drivers Table 99. Combined hormonal contraceptive Market Restraints Table 100. Global Combined hormonal contraceptive Sales Forecast by Type (2022-2027) & (K MT) Table 101. Global Combined hormonal contraceptive Sales Market Share Forecast by Type (2022-2027) Table 102. Global Combined hormonal contraceptive Revenue Forecast by Type (2022-2027) & (US$ Million) Table 103. Global Combined hormonal contraceptive Revenue Market Share Forecast by Type (2022-2027) Table 104. Global Combined hormonal contraceptive Sales Forecast by Application (2022-2027) & (K MT) Table 105. Global Combined hormonal contraceptive Sales Market Share Forecast by Application (2022-2027) Table 106. Global Combined hormonal contraceptive Revenue Forecast by Application (2022-2027) & (US$ Million) Table 107. Global Combined hormonal contraceptive Revenue Market Share Forecast by Application (2022-2027) Table 108. Global Combined hormonal contraceptive Sales Forecast by Region (2022-2027) & (K MT) Table 109. Global Combined hormonal contraceptive Sales Market Share Forecast by Region (2022-2027) Table 110. Global Combined hormonal contraceptive Revenue Forecast by Region (2022-2027) & (US$ Million) Table 111. Global Combined hormonal contraceptive Revenue Market Share Forecast by Region (2022-2027) Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Combined hormonal contraceptive Figure 2. Global Combined hormonal contraceptive Market Share by Type in 2020 & 2027 Figure 3. Pills Product Picture Figure 4. Patch Product Picture Figure 5. Ring Product Picture Figure 6. Global Combined hormonal contraceptive Market Share by Application in 2020 & 2027 Figure 7. Hospital Pharmacies Figure 8. Retail Pharmacies Figure 9. E-commerce Figure 10. Others Figure 11. Global Combined hormonal contraceptive Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Combined hormonal contraceptive Market Size 2016-2027 (US$ Million) Figure 13. Global Combined hormonal contraceptive Sales 2016-2027 (K MT) Figure 14. Global Combined hormonal contraceptive Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Combined hormonal contraceptive Sales Share by Manufacturers in 2020 Figure 16. Global Combined hormonal contraceptive Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Combined hormonal contraceptive Players: Market Share by Revenue in 2020 Figure 18. Combined hormonal contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Combined hormonal contraceptive Sales Market Share by Region (2016-2021) Figure 20. Global Combined hormonal contraceptive Sales Market Share by Region in 2020 Figure 21. Global Combined hormonal contraceptive Revenue Market Share by Region (2016-2021) Figure 22. Global Combined hormonal contraceptive Revenue Market Share by Region in 2020 Figure 23. U.S. Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. U.A.E Combined hormonal contraceptive Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Combined hormonal contraceptive by Type (2016-2021) Figure 48. Sales Market Share of Combined hormonal contraceptive by Application (2016-2021) Figure 49. Sales Market Share of Combined hormonal contraceptive by Application in 2020 Figure 50. Revenue Share of Combined hormonal contraceptive by Application (2016-2021) Figure 51. Revenue Share of Combined hormonal contraceptive by Application in 2020 Figure 52. Manufacturing Cost Structure of Combined hormonal contraceptive Figure 53. Manufacturing Process Analysis of Combined hormonal contraceptive Figure 54. Combined hormonal contraceptive Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Teva Pharmaceutical Industries Bayer HealthCare Pharmaceuticals Actavis Pfizer Johnson & Johnson GlaxoSmithKline Watson Pharma Cipla Novartis International